FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310147684> ?p ?o ?g. }

• W4310147684 endingPage "388" @default.
• W4310147684 startingPage "380" @default.
• W4310147684 abstract "(1) Background: Obesity is a global epidemic issue that has increased greatly in recent decades. Although interventions such as nutritional approaches and the practice of physical exercise are potential therapies to combat obesity, in some cases they are not sufficient. Therefore, the development of new pharmacological treatments is necessary. Combining these therapies with non-pharmacological alternatives could be an interesting strategy for treating obesity. Considered a pharmacological treatment for overactive bladder (OAB), mirabegron is also categorized as a β(3)-adrenoceptor agonist, and is used in recommended doses of 25 mg and 50 mg. Animal models have shown that the administration of 0.8 mg/kg of mirabegron leads to elevated activation of brown adipose tissue (BAT) and white adipose tissue (WAT) browning. (2) Results: Findings suggest that the pharmacological application of mirabegron has numerous beneficial effects in lipid metabolism, suggesting a potential action against obesity. In this context, physical exercise and mirabegron stimulate browning activation using different mechanisms. (3) Conclusions: According to the results of the studies presented in this review, mirabegron may be a promising pharmacological treatment for obesity due to its significant effects on estimated energy expenditure (EER) through thermogenesis elevation, BAT activation, and WAT browning seen in dosages up to 100 mg. In addition, the administration of mirabegron combined with physical exercise may be a potential alternative for increasing the body’s energy expenditure, with actions in distinct signaling pathways. Thus, physical exercise combined with mirabegron can alleviate some adverse side effects encountered with the use of the medication. Finally, although there have been advances in knowledge, more studies are needed to understand the combined effects of using mirabegron and physical exercise." @default.
• W4310147684 created "2022-11-30" @default.
• W4310147684 creator A5020050296 @default.
• W4310147684 creator A5048421846 @default.
• W4310147684 creator A5077722331 @default.
• W4310147684 creator A5091855499 @default.
• W4310147684 date "2022-11-26" @default.
• W4310147684 modified "2023-10-17" @default.
• W4310147684 title "Mirabegron and Physical Exercise Is a Potential Strategical for BAT Activation in Obesity" @default.
• W4310147684 cites W1127264686 @default.
• W4310147684 cites W1200115021 @default.
• W4310147684 cites W1965079305 @default.
• W4310147684 cites W2005256857 @default.
• W4310147684 cites W2005827500 @default.
• W4310147684 cites W2013891116 @default.
• W4310147684 cites W2025870581 @default.
• W4310147684 cites W2063287662 @default.
• W4310147684 cites W2065453240 @default.
• W4310147684 cites W2085397620 @default.
• W4310147684 cites W2145142659 @default.
• W4310147684 cites W2147627509 @default.
• W4310147684 cites W2164410780 @default.
• W4310147684 cites W2413190348 @default.
• W4310147684 cites W2567527171 @default.
• W4310147684 cites W2602474125 @default.
• W4310147684 cites W2791665060 @default.
• W4310147684 cites W2800024870 @default.
• W4310147684 cites W2848110103 @default.
• W4310147684 cites W2890400818 @default.
• W4310147684 cites W2903823484 @default.
• W4310147684 cites W2926267031 @default.
• W4310147684 cites W2945045299 @default.
• W4310147684 cites W2946118461 @default.
• W4310147684 cites W2964913070 @default.
• W4310147684 cites W3001317202 @default.
• W4310147684 cites W3001593379 @default.
• W4310147684 cites W3047205014 @default.
• W4310147684 cites W3135240047 @default.
• W4310147684 cites W3164422024 @default.
• W4310147684 cites W3175303006 @default.
• W4310147684 cites W3190980765 @default.
• W4310147684 cites W3202675153 @default.
• W4310147684 cites W3214265581 @default.
• W4310147684 cites W4220843365 @default.
• W4310147684 cites W4221050645 @default.
• W4310147684 cites W4283644781 @default.
• W4310147684 cites W4283777973 @default.
• W4310147684 cites W4285092061 @default.
• W4310147684 cites W4295956898 @default.
• W4310147684 cites W4297982293 @default.
• W4310147684 cites W4308921576 @default.
• W4310147684 doi "https://doi.org/10.3390/obesities2040032" @default.
• W4310147684 hasPublicationYear "2022" @default.
• W4310147684 type Work @default.
• W4310147684 citedByCount "0" @default.
• W4310147684 crossrefType "journal-article" @default.
• W4310147684 hasAuthorship W4310147684A5020050296 @default.
• W4310147684 hasAuthorship W4310147684A5048421846 @default.
• W4310147684 hasAuthorship W4310147684A5077722331 @default.
• W4310147684 hasAuthorship W4310147684A5091855499 @default.
• W4310147684 hasBestOaLocation W43101476841 @default.
• W4310147684 hasConcept C126322002 @default.
• W4310147684 hasConcept C134018914 @default.
• W4310147684 hasConcept C142724271 @default.
• W4310147684 hasConcept C151730666 @default.
• W4310147684 hasConcept C151955695 @default.
• W4310147684 hasConcept C171089720 @default.
• W4310147684 hasConcept C197934379 @default.
• W4310147684 hasConcept C204787440 @default.
• W4310147684 hasConcept C2778164427 @default.
• W4310147684 hasConcept C2778941218 @default.
• W4310147684 hasConcept C2779343474 @default.
• W4310147684 hasConcept C2780642333 @default.
• W4310147684 hasConcept C2988147884 @default.
• W4310147684 hasConcept C511355011 @default.
• W4310147684 hasConcept C71924100 @default.
• W4310147684 hasConcept C86803240 @default.
• W4310147684 hasConcept C98274493 @default.
• W4310147684 hasConceptScore W4310147684C126322002 @default.
• W4310147684 hasConceptScore W4310147684C134018914 @default.
• W4310147684 hasConceptScore W4310147684C142724271 @default.
• W4310147684 hasConceptScore W4310147684C151730666 @default.
• W4310147684 hasConceptScore W4310147684C151955695 @default.
• W4310147684 hasConceptScore W4310147684C171089720 @default.
• W4310147684 hasConceptScore W4310147684C197934379 @default.
• W4310147684 hasConceptScore W4310147684C204787440 @default.
• W4310147684 hasConceptScore W4310147684C2778164427 @default.
• W4310147684 hasConceptScore W4310147684C2778941218 @default.
• W4310147684 hasConceptScore W4310147684C2779343474 @default.
• W4310147684 hasConceptScore W4310147684C2780642333 @default.
• W4310147684 hasConceptScore W4310147684C2988147884 @default.
• W4310147684 hasConceptScore W4310147684C511355011 @default.
• W4310147684 hasConceptScore W4310147684C71924100 @default.
• W4310147684 hasConceptScore W4310147684C86803240 @default.
• W4310147684 hasConceptScore W4310147684C98274493 @default.
• W4310147684 hasIssue "4" @default.
• W4310147684 hasLocation W43101476841 @default.
• W4310147684 hasLocation W43101476842 @default.

• next